Evidence map›Paper›PMID 34350153›Full record

ReviewFrontiers in public health

Laboratory Readiness and Response for SARS-Cov-2 in Indonesia.

Dewi N Aisyah, Chyntia A Mayadewi, Gayatri Igusti, Logan Manikam, Wiku Adisasmito, Zisis Kozlakidis

Abstract readReview
In one paragraph

Review in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The COVID-19 laboratory response in Timor-Leste; a story of collaboration.The Lancet regional health. Southeast Asia · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dewi N AisyahDepartment of Epidemiology and Public Health, Institute of Epidemiology and Health Care, University College London, London, United Kingdom.
Chyntia A MayadewiIndonesia One Health University Network, Depok, Indonesia.
Gayatri IgustiAceso Global Health Consultants Limited, London, United Kingdom.
Logan ManikamDepartment of Epidemiology and Public Health, Institute of Epidemiology and Health Care, University College London, London, United Kingdom.
Wiku AdisasmitoIndonesia One Health University Network, Depok, Indonesia.
Zisis KozlakidisInternational Agency for Research on Cancer World Health Organization, Lyon, France.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The laboratory diagnosis of SARS-CoV-2 infection comprises the informational cornerstone in the effort to contain the infections. Therefore, the ability to leverage laboratories' capacity in diagnostic testing and to increase the number of people being tested are critical. This paper reviews the readiness of Indonesian laboratories during the early months of the pandemic. It discusses the success of cross-sectoral collaboration among previously siloed national and sub-national government institutions, international development agencies, and private sector stakeholders. This collaboration managed to scale-up the COVID-19 referral laboratory network from one Ministry of Health NIHRD laboratory in the capital to 685 laboratories across 34 provinces. However, this rapid growth within 12 months since the first Indonesian case was discovered remained insufficient to cater for the constantly surging testing demands within the world's fourth most populous country. Reflecting on how other countries built their current pandemic preparedness from past emergencies, this paper highlights challenges and opportunities in workforce shortage, logistic distribution, and complex administration that need to be addressed.

Indexed as

COVID-19SARS-CoV-2HumansIndonesiaLaboratoriesPandemicsIndonesialaboratory readinesspandemicsresponseSARS-CoV-2

Identifiers

PMID34350153
PMCPMC8326463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.